Patient Centricity WG

About this WG

This WG looks into topics related to patient engagement into drug and medical device regulations in order to enhance the incorporation of the patient’s voice in activities of PMDA.

Established

May, 2019

Members

Office of Planning and Operations
Office of International Programs
Office of New Drug I-V
Office of Cellular and Tissue-based Products
Office of Vaccines and Blood Products
Office of Medical Devices I-II
Office of Informatics and Management for Safety
Office of Pharmacovigilance I-II
Office of Medical Informatics and Epidemiology
Office of Review Management
Office of Research Promotion

Document

Pharmaceuticals and Medical Devices Agency Guidance on Patient Participation (September 7, 2021)